Calidi Biotherapeutics (NYSEMKT: CLDI)
$1.57
(0.6%)
$0.01
Price as of October 3, 2025, 3:03 p.m. ET
Calidi Biotherapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Calidi Biotherapeutics Company Info
First Light Acquisition Group Focuses on identifying dual-use, technology-enabled solutions with mission-critical applications in large and rapidly growing markets.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.